← Back to Patent Explorer
US3828777A Expired / Lapsed US ⏱️ 0.0 years remaining

Microporous ocular device

Assignee: Alza Corp
•
Filing: 1971-11-08
•
Granted: 1974-08-13
•
Expires: 1991-11-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An ocular device for the controlled and continuous administration of a predetermined dosage of drug to the eye comprising a body of microporous drug release rate controlling material which is insoluble in tear fluid, the pores of which are filled with a medium permeable to the passage of drug by diffusion. The body contains a reservoir of drug formulation confined therein which is of limited solubility in the medium, and is of a shape which is adapted for insertion and retention in the sac of the eye bounded by the surfaces of the bulbar conjunctiva of the sclera of the eyeball and the palpebral conjunctiva of the lid. The body continuously meters the flow of a therapeutically effective amount of drug to the eye and surrounding tissues at a controlled and reproducible rate over a prolonged period of time. The device is so constructed that the metering is determined by the rate of diffusion of drug in the diffusive medium.

Inventors

  • 👤 R Ness

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 16:40
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/0008; A61F9/0017; A61K; A61K9/00; A61K9/0012; A61K9/0048; A61K9/0051

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 219 words
An ocular device for the controlled and continuous administration of a predetermined dosage of drug to the eye over a prolonged period of time comprising a body of a polymeric microporous drug release rate controlling material which is insoluble in tear fluid, the pores of which are filled with a liquid or gel medium permeable to the passage of drug by diffusion, the body containing a reservoir of drug formulation confined therein which is of limited solubility in the medium such that the passage of drug through the medium is less than its rate of clearance from the exterior of the body and being of a shape which is adapted for insertion and retention in the sac of the eye bounded by the surfaces of the bulbar conjunctiva of the sclera of the eyeball and the palpebral conjunctiva of the lid, the body continuously metering the flow of a therapeutically effective amount of drug to the eye and surrounding tissues over a prolonged period of time at a rate determined by the rate of diffusion of drug in the diffusive medium and wherein the body is a sealed container, the walls of which are formed from the microporous release rate controlling material and define an interior chamber distinct from the pores of said material, said chamber forming said reservoir.
Claim 2
Dependent Claim 219 words
An ocular device for the controlled and continuous administration of a predetermined dosage of drug to the eye over a prolonged period of time comprising a body of a polymeric microporous drug release rate controlling material which is insoluble in tear fluid, the pores of which are filled with a liquid or gel medium permeable to the passage of drug by diffusion, the body containing a reservoir of drug formulation confined therein which is of limited solubility in the medium such that the passage of drug through the medium is less than its rate of clearance from the exterior of the body and being of a shape which is adapted for insertion and retention in the sac of the eye bounded by the surfaces of the bulbar conjunctiva of the sclera of the eyeball and the palpebral conjunctiva of the lid, the body continuously metering the flow of a therapeutically effective amount of drug to the eye and surrounding tissues over a prolonged period of time at a rate determined by the rate of diffusion of drug in the diffusive medium and wherein the body is a sealed container, the walls of which are formed from the microporous release rate controlling material and define an interior chamber distinct from the pores of said material, said chamber forming said reservoir.
Claim 3
Dependent Claim 24 words
The ocular device of claim 1, wherein the body is a matrix of microporous release rate controlling material having the drug formulation distributed therethrough.
Claim 4
Dependent Claim 18 words
The ocular device of claim 1, wherein the drug formulation comprises a drug in a solid carrier material.
Claim 5
Dependent Claim 18 words
The ocular device of claim 1, wherein the drug formulation comprises a drug in a liquid carrier material.
Claim 6
Dependent Claim 16 words
The ocular device of claim 3, wherein the drug is sparingly soluble in the carrier material.
Claim 7
Dependent Claim 16 words
The ocular device of claim 4, wherein the drug is sparingly soluble in the carrier material.
Claim 8
Dependent Claim 13 words
The ocular device of claim 1, wherein the diffusive medium is lacrimal fluid.
Claim 9
Dependent Claim 22 words
The ocular device of claim 1, wherein the drug solubility in the diffusive medium is from 10 to 5,000 parts per million.
Claim 10
Dependent Claim 32 words
The ocular device of claim 1, wherein the microporous material has an effective pore size of from 10 angstroms to 100 microns and a porosity of from 5 percent to 95 percent.

References Cited (Backward Citations)

US2846057A Cited
US3053255A Cited
US3075527A Cited
US3220960A Cited
US3426754A Cited
US3416530A Cited
US3598123A Cited
US3618604A Cited
US3630200A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-08-12 1978-02-11 1978-08-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-08-12 1982-02-11 1982-08-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-08-12 1986-02-11 1986-08-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag